Robert C. Goeltz, II
2021
Compensation breakdown
| Non-Equity Incentive Plan | $175,000 |
|---|---|
| Option Awards | $1,847,145 |
| Salary | $435,000 |
| Stock Awards | $459,125 |
| Other | $3,200 |
| Total | $2,919,470 |
Goeltz received $1.8M in option awards, accounting for 63% of the total pay in 2021.
Goeltz also received $175K in non-equity incentive plan, $435K in salary, $459.1K in stock awards and $3.2K in other compensation.
Rankings
In 2021, Robert C. Goeltz, II's compensation ranked 4,531st out of 12,406 executives tracked by ExecPay. In other words, Goeltz earned more than 63.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,531 out of 12,406 | 64th |
Division Manufacturing | 1,873 out of 5,492 | 66th |
Major group Chemicals And Allied Products | 778 out of 2,368 | 67th |
Industry group Drugs | 692 out of 2,089 | 67th |
Industry Pharmaceutical Preparations | 493 out of 1,536 | 68th |
Pay ratio
| Robert C. Goeltz, II's Pay | $2,919,470 |
|---|---|
| Median Employee's Pay | $296,616 |
| Pay Ratio | 10to 1 |
In 2021, the annual total compensation of Robert C. Goeltz, II was $2,919,470.
The annual total compensation of the median employee at Arcus Biosciences was $296,616.
The ratio of Robert C. Goeltz, II's pay to the pay of median employee was therefore 10 to one.
Goeltz's colleagues
We found five more compensation records of executives who worked with Robert C. Goeltz, II at Arcus Biosciences in 2021.